Condition
Cervical Cytology
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Unknown4
Enrolling By Invitation1
Clinical Trials (5)
Showing 5 of 5 trials
NCT06767111Enrolling By InvitationPrimary
Techcyte SureView Cervical Cytology System Clinical Validation Study
NCT05309122Unknown
Cervical Cancer Screening Strategies
NCT05290922Unknown
DNA CDO1 and CELF4 Methylation for Endometrial Cancer Screening
NCT05290415Unknown
Host DNA Methylation for Endometrial Cancer Screening
NCT04651738Not ApplicableUnknown
Cell-free DNA Methylation for Endometrial Cancer
Showing all 5 trials